Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Jacek Brązert"'
Autor:
Aneta Malinowska-Polubiec, Agnieszka Zawiejska, Ewa Romejko-Wolniewicz, Grzegorz Poprawski, Iwona Towpik, Jacek Brązert, Zuzanna Handziuk, Krzysztof Czajkowski
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionDouble diabetes (DDiab) is defined as T1DM coexisting with insulin resistance (IR), metabolic syndrome (MetS), and/or obesity. Little evidence is available regarding how frequent DDiab is among T1DM pregnancies and whether it affects the
Externí odkaz:
https://doaj.org/article/ce41bd79a8ea47edbdd633ebab47bdf1
Autor:
Rafał Iciek, Paweł Gutaj, Sara Królik, Grażyna Kurzawińska, Anna Bogacz, Agnieszka Seremak-Mrozikiewicz, Przemysław Mikołajczak, Jacek Brązert, Ewa Wender-Ożegowska
Publikováno v:
Clinical Diabetology. 12:38-44
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::735fd3cb2786dc97d6e9e544f0f10e06
https://doi.org/10.5603/dk.a2022.0056
https://doi.org/10.5603/dk.a2022.0056
Autor:
Jacek Brązert, Agnieszka Lewicka-Rabska, Rafał Iciek, Przemysław Mikołajczak, Anna Bogacz, Agnieszka Zawiejska, Maciej Brązert
Publikováno v:
Acta Diabetologica. 59:259-267
Aim Hyperglycaemia diagnosed in pregnancy (HiP) is a serious and frequent complication of pregnancy, increasing the risk for adverse maternal and neonatal outcomes. Investigate whether allelic variations of the glucocorticoid receptor are related to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::045088a8c977b2884b9cc73bef43ab1c
https://doi.org/10.1007/s00592-021-01799-3
https://doi.org/10.1007/s00592-021-01799-3
Publikováno v:
Donald School Journal of Ultrasound in Obstetrics and Gynecology. 14:222-225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b3ad469667754a2986d97a6c817a15b
https://doi.org/10.5005/jp-journals-10009-1657
https://doi.org/10.5005/jp-journals-10009-1657
Publikováno v:
Donald School Journal of Ultrasound in Obstetrics and Gynecology. 14:178-194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee78a354b455d2c59da065cee14320ca
https://doi.org/10.5005/jp-journals-10009-1660
https://doi.org/10.5005/jp-journals-10009-1660
Publikováno v:
Minerva Endocrinology. 46
Visfatin is an adipokine produced and secreted by the adipose tissue. It exerts an insulin-like effect by the insulin receptor-1 and has a hypoglycemic effect. We aimed to investigate how serum visfatin changes in women with gestational diabetes mell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e985a4fc2522940324d80650c60be500
https://doi.org/10.23736/s2724-6507.20.03280-0
https://doi.org/10.23736/s2724-6507.20.03280-0
Autor:
Marek Pietryga, Jacek Brązert, Ewa Florek, Kinga Tobola-Wrobel, Piotr Dydowicz, Marta Napierała
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2020 (2020)
The pathophysiological mechanism underlying pregnancy complications such as congenital malformations, miscarriage, preeclampsia, or fetal growth restriction is not entirely known. However, the negative impact of the mother’s body oxidative imbalanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::341b0052397d089ba8d2641274931edf
Publikováno v:
Ginekologia Polska. 89:518-521
Gestational diabetes (GDM) is defined as a glucose intolerance of varying severity with onset or first recognition during pregnancy. Two major metabolic disorders: insulin resistance and β-cells dysfunction, play currently major role in pathogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7a8f73819b703a150e76ca1d82f7d03
https://doi.org/10.5603/gp.a2018.0088
https://doi.org/10.5603/gp.a2018.0088
Autor:
Radosław Januchowski, Michał Nowicki, Monika Świerczewska, Andrzej Klejewski, Jacek Brązert, Karolina Sterzyńska, Karolina Wojtowicz
Publikováno v:
Journal of Cancer
Background: Low effectiveness of chemotherapy in ovarian cancer results from development of drug resistance during treatment. Topotecan (TOP) is a chemotherapeutic drug used in second-line chemotherapy of this cancer. Unfortunately, during treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4096dd1f41b5310db2233801b0005584
https://doi.org/10.7150/jca.27342
https://doi.org/10.7150/jca.27342
Autor:
Marek Pietryga, Jacek Brązert, Katarzyna Ziolkowska, Piotr Dydowicz, Agnieszka Zawiejska, Anna Gąsiorowska, Hubert Wolski
Publikováno v:
Ginekologia Polska. 88:87-95
Objectives: SGA is associated with higher incidence of postnatal complications, including suboptimal neurodevelopment and increased cardiovascular risk. Screening for SGA, carried out at 11–13 (+ 6d) gestational weeks enables to reduce or completel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b816c86bbab08ce5021d192e27f2f3a4
https://doi.org/10.5603/gp.a2017.0021
https://doi.org/10.5603/gp.a2017.0021